Integra equipped the internationally renowned Russian Federal Cancer Research Center named after N.N. Blochin with a full radiopharmaceutical laboratory as well as a 18/9 cyclotron.
Integra provides the Cancer Research Center with the first ever IBA cyclotron system in Russia. This investment will bring the N.N. Blokhin Cancer Research Center into line with the standards of top international facilities. Thus, patients will profit from the benefits of the newest methods in laboratory medicine and the most elaborated imaging diagnostics, such as PET-CT imaging. Production of the the PET tracers follows strict cGMP (Current Good Manufacturing Practice) principles and guidelines.

The N.N. Blokhin Cancer Research Center comprises of four separate institutes, including a 1,600-bed hospital devoted to cancer patients. It is one of the largest Oncological Research Centers in Europe, employing approximately 700 scientists and 2,000 medical personnel.